Including most countries in europe.

Cerimon also announced that it lately received notification from america Patent and Trademark Office allowing patent promises covering its diclofenac patch. There is a growing doctor and patient curiosity in prescription therapies that may deliver safe, effective and convenient site-specific pain administration. We believe our patch will be able to address this interest, and by acquiring the European rights to our diclofenac patch, we desire to bring safe and effective pain relief to a larger patient population, mentioned James S. Shannon, M.D., CEO of Cerimon Pharmaceuticals. An interview with Professor Lesley JonesCerimon also announced today that it completed enrollment of its Phase 3 system evaluating the business’s diclofenac patch for the treating acute agony. Continue reading

Biologists identify system of H.

Biologists identify system of H. Pylori that damages DNA of gastric mucosal cells The tummy bacterium Helicobacter pylori is among the biggest risk elements for the advancement of gastric cancer, the 3rd most common reason behind cancer-related deaths in the globe. Molecular biologists from the University of Zurich have finally identified a system of Helicobacter pylori that damages the DNA of cells in the gastric mucosa and units them up for malignant transformation. Gastric cancers is among the most common and frequently fatal cancers: Every third malignancy death is because of gastric carcinoma. The primary risk element for the advancement of gastric cancer may be the chronic contamination of the gastric mucosa with the bacterium Helicobacter pylori. Continue reading

CDC: Way too many young teens still giving birth Despite record lows.

These may reflect differences in demographics, poverty rates, rates of sexual activity and distinctions in attitudes among teenagers in these certain areas, based on the CDC. The CDC called for more educational applications to target teens, in communities and groups that are more affected especially. The full report was also released April 8 in the CDC’s journal Morbidity and Mortality Weekly Report.. CDC: Way too many young teens still giving birth Despite record lows, the Centers for Disease Control and Prevention is warning that younger teens between ages 15 and 17 still account for one out of 4 teen births, or around 1,700 births each full week – – and that number needs to be reduced. Continue reading

CRF Health gives gold regular ePRO education.

Not only will be the topics timely in moving the ePRO sector forward, but they show CRF Health’s commitment to help expand advance paperless trials. .. CRF Health gives gold regular ePRO education, demonstrates dedication to advance paperless trials CRF Health, a leading global company of ePRO solutions for the full life Sciences Industry, today announced a series of upcoming conferences that will feature presentations by CRF Health’s ePRO specialists. Continue reading

AstraZeneca and Targacept Type Global Collaboration and Licence Contract Targacept and AstraZeneca.

Bristol-Myers Squibb initiated on July 28, 2009, through its wholly-owned subsidiary Puma Acquisition Company, a cash tender offer to purchase all excellent shares of common share of Medarex for $16 per share. The expiration of the HSR waiting period satisfies one of the conditions to the tender present, which will expire at 12 midnight on Monday, August 24, 2009, unless extended relative to the merger agreement and the applicable regulations and rules of the SEC. Continue reading

CEO of Good Start GeneticsDiabetic retinopathy therapy innovations: an interview with Richard Kirk.

CellTrust’s Secure Mobile Health care application suite is made on highly encrypted, HIPAA compliant SecureSMS texting technology that enhances delivery of real-time Protected Wellness Information to health care providers’, payers’ and sufferers’ mobile devices via Text message. Supply CellTrust Corporation.. CellTrust to showcase secure cellular healthcare solution at HIMSS Related StoriesGenetic carrier screening: an interview with Don Hardison, CEO of Good Start GeneticsDiabetic retinopathy therapy innovations: an interview with Richard Kirk, CEO of PolyphotonixRE.WORK showcases future innovations and technology in deep learning softwareCellTrust Corporation, the world’s largest provider of SecureSMS for cell phones between healthcare institutions, patients and providers, said Sean Moshir, Chairman and CEO of CellTrust. Continue reading

Birth control supplements recalled: Which brands?

Birth control supplements recalled: Which brands? A lot more than 1 million deals of contraceptive pills have already been recalled. What’s the issue? Ladies taking them could get pregnant. Whoops. Qualitest Pharmaceuticals released a nationwide recall of just one 1.4 million oral contraceptives over a packaging mistake. Some blister packs had been rotated 180 degrees, and the defective product packaging may inadvertently cause ladies to take the wrong birth control dose, leaving them without sufficient safety. There aren’t any instant health threats from the mistake, according an FDA created statement. Continue reading

Arizonas smoking ban reduces hospital admissions for stroke.

Reductions in hospital fees are estimated to total more than $16 million in the first 13 months following the ban. Patricia M. Herman and Michele E. Walsh, both researchers in the UA psychology division, used public data on monthly hospital admissions in Arizona from January 2004 through May 2008 because of their analyses. Related StoriesFirst medical center installs Ortho Vision AnalyzerScreening for asymptomatic atrial fibrillation could reduce risk of stroke, premature deathCHOP's Buerger Center for Advanced Pediatric Care celebrates grand openingTo control for other reasons why hospital admissions modification over time, they compared admissions for those major diagnoses before and after Might 1, 2007 – the beginning date of the smoking ban – to admissions for four diagnoses not associated with secondhand smoke: appendicitis, kidney stones, acute ulcers and cholecystitis. Continue reading

Cipher Stage 3 dermatology research uses MedAvante Centralized Ratings MedAvante.

Cipher Stage 3 dermatology research uses MedAvante Centralized Ratings MedAvante, Inc., the leader in centralized professional evaluation of remedies for central nervous system disorders, announced that Cipher Pharmaceuticals is certainly using MedAvante Centralized Ratings in their pivotal Phase 3 dermatology study. Related StoriesRXI-109 use after scar revision surgery has beneficial influence on suppression of hypertrophic scarringTips to treat, prevent common wartsAdvanced pneumatic compression device reduces cellulitis episodes, will save money for lymphedema patients’Clinical studies require specific and advanced methodologies that are highly accurate and reproducible, and at exactly the same time with the capacity of assuring patient basic safety,’ stated Dr. Continue reading

Two sets of researchers have found new evidence that loss of DJ-1.

Animal model of Parkinson’s disease reveals impressive sensitivity to common environmental toxins In findings that support a relationship between agricultural chemicals and Parkinson’s disease, two sets of researchers have found new evidence that loss of DJ-1, a gene known to be associated with inherited Parkinson’s disease, leads to impressive sensitivity to the herbicide paraquat and the insecticide rotenone. The two studies had been performed with the fruit fly Drosophila, a used model organism for research of human disease broadly, and shed new light on biological connections between inherited and sporadic forms of Parkinson’s disease http://www.finast.net/ . Continue reading